age-related macular degeneration

New Discoveries Offer Hope for Failing Eyes

Mindy Hartman — Thu, 01 Oct 2009 22:28:07 -0500

The number of Americans with age-related macular degeneration is expected to skyrocket as the U.S. population grows older.

What Might Declining Night Vision Mean for AMD Patients?

harminka — Mon, 03 Nov 2008 11:08:54 -0600

The Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) Research Group assessed night vision in a cohort of 1,052 CAPT patients.

Drug candidate slows age-related macular degeneration

harminka — Fri, 10 Oct 2008 07:55:18 -0500

Research results from the Case Western Reserve University School of Medicine show that the progression of age-related macular degeneration (AMD) is markedly slowed in new laboratory-engineered mice when they received treatments of retinylamine, a trial drug that has been tested in a medical school lab. AMD is a leading cause of vision loss in Americans 60 years of age and older.

Genetic finding implicates innate immune system in major cause of blindness

harminka — Wed, 08 Oct 2008 09:49:04 -0500

The research, published online today in the Lancet, adds to the growing understanding of the genetics of age-related macular degeneration (AMD), which the researchers believe should ultimately lead to novel treatments for the disease.

Low-Luminance Study Yields New Predictive Tool

harminka — Tue, 02 Sep 2008 14:02:56 -0500

Janet S. Sunness, M.D., Director of the Hoover Low Vision Services at the Greater Baltimore Medical Center, and her fellow researchers have discovered a simple and inexpensive way to predict the rapid loss of visual acuity, the ability to see detail, in “dry” AMD patients.

CAPT Study Findings on Advanced AMD

harminka — Tue, 02 Sep 2008 14:00:27 -0500

The Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) was a multicenter randomized clinical trial (conducted from 1999 to 2005) that investigated whether low-intensity laser treatment could prevent vision loss in patients with early stage age-related macular degeneration (AMD).

First gene associated with dry macular degeneration found

harminka — Thu, 28 Aug 2008 10:26:12 -0500

In a study that underscores the important role that individual genetic profiles will play in the development of new therapies for disease, a multi-institutional research team – led by Kang Zhang, MD, PhD professor of ophthalmology and human genetics at Shiley Eye Center at the University of California, San Diego, School of Medicine – has made two important discoveries related to age-related macular degeneration (AMD), the leading cause of blindness in adults over the age of 60.

Genetic link to dry macular degeneration found

harminka — Thu, 28 Aug 2008 10:07:49 -0500

A University of Kentucky ophthalmologist, along with a team of scientists, has discovered a genetic mutation that offers protection against a type of age-related macular degeneration (AMD), a disease of the eye that is the leading cause of blindness in adults over age 50.

Eat oily fish at least once week to protect your eyesight in old age

harminka — Fri, 08 Aug 2008 13:13:44 -0500

Eating oily fish once a week may reduce age-related macular degeneration (AMD) which is the major cause of blindness and poor vision in adults in western countries and the third cause of global blindness, according to a study published today in the American Journal of Clinical Nutrition.

Age-Related Macular Degeneration in an Asian Population

harminka — Sat, 02 Aug 2008 04:52:17 -0500

AMD erodes and can eventually destroy the central vision needed for reading, driving, and other daily tasks. When AMD risk levels among racial and ethnic groups are compared, Caucasians are usually identified as at highest risk. Asians in particular have been assumed to have lower risk.

Hyperactive immune resistance brings blindness in old age

harminka — Fri, 25 Jul 2008 01:19:26 -0500

Age-dependent macular degeneration (AMD) is the commonest cause of blindness in the western industrialised nations. Hereditary changes in the regulation of the immune system influence the risk of contracting AMD.

Hormone use related to lower risk of macular degeneration in postmenopausal women

harminka — Tue, 15 Apr 2008 12:56:59 -0500

Women who take postmenopausal hormones appear to have a lower risk of developing advanced stages of the eye disease age-related macular degeneration, especially if they had also taken oral contraceptives in the past, according to a report in the April issue of Archives of Ophthalmology, one of the JAMA/Archives journals.